Quick Answer
Minerva Neurosciences, Inc. reported Stockholders Equity of -$140.75 million for fiscal year 2025.
Minerva Neurosciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$140.75M | -447.8% |
| 2024 | -$25.69M | +9.7% |
| 2023 | -$28.46M | -42.1% |
| 2022 | -$20.02M | -351.1% |
| 2021 | $7.98M | -84.9% |
| 2020 | $52.66M | +89.6% |
| 2019 | $27.78M | -69.2% |
| 2018 | $90.26M | -31.4% |
| 2017 | $131.60M | +24.2% |
| 2016 | $105.98M | +91.6% |
| 2015 | $55.32M | +7.4% |
| 2014 | $51.50M | +155.2% |
| 2013 | $20.18M | +106002.3% |
| 2012 | $19.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$34.58M | -59.6% | -7.7% |
| June 30, 2025 | -$32.11M | +27.8% | -10.2% |
| March 31, 2025 | -$29.15M | +20.3% | -13.5% |
| December 31, 2024 | -$25.69M | +9.7% | -18.6% |
| September 30, 2024 | -$21.67M | -8.1% | +51.3% |
| June 30, 2024 | -$44.49M | -255.6% | -21.6% |
| March 31, 2024 | -$36.59M | -37.5% | -28.6% |
| December 31, 2023 | -$28.46M | -42.1% | -42.0% |
- Minerva Neurosciences, Inc. showed a decrease of -447.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, Minerva Neurosciences, Inc.’s stockholders equity has declined by 740139.3% (from $19.0 thousand to -$140.75 million).
- The most recent figure is from Minerva Neurosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: